Tiffany comes to Optime Care with over 25 years of global healthcare and bio-pharmaceutical experience with a proven track record across pre-clinical, clinical and commercialization in early to late-stage Global Oncology and Rare Disease companies. She played a key role in strategic and operational planning to optimize value creation, and in defining and developing the pre-commercialization to commercialization path, working across the organization to exceed corporate revenue and brand goals.
Prior to joining Optime Care, Tiffany was Vice President/Head of Commercial for ProQR Therapeutics, where she successfully developed the global infrastructure and US organization as well as instituted an operational launch readiness roadmap, including functions, systems, processes, employees and resources, across the organization to support multiple launches within the Inherited Retinal Disease portfolio.
Tiffany also held other senior level management roles within the pharmaceutical and biotech industry such as Vice President, Marketing at Verastem Oncology, Senior Global Director at EMD Serono, Global Product Director at ARIAD Pharmaceuticals, Director of US Oncology Marketing at Iclusig and CML Senior Manager and Hematology Sales Specialist at Novartis Oncology.
Tiffany holds a Bachelor’s Degree in Arts & Psychology from Vanderbilt University and an MBA from Webster University. She is an active Women-in-Bio committee member along with being a previous, LEAP Judge at Washington University in St. Louis for Interdisciplinary Innovation & Entrepreneurship.